Skip to main content
. 2022 Jan 1;32(6):3617–3630. doi: 10.1007/s00330-021-08450-3

Table 1.

Demographic characteristics and ultrasound features of 329 follicular thyroid neoplasms

Demographic characteristics No. (%) or mean ± SD (range)
Male 113 (34.3)
Age (years) 43.5 ± 14.3 (3–82)
Pathological classifications
FTA 262 (79.6)
FTC 67 (20.4)
Minimally invasive 48 (14.7)
Encapsulated angioinvasive 12 (3.6)
Widely invasive 7 (2.1)
Ultrasound features
Maximum diameters (cm)a 3.6 ± 1.7 (0.6–12.1)
Maximum diameters > 2 cma 285 (86.9)
Maximum diameters > 4 cma 135 (41.2)
Location Left 167 (50.8)
Right 157 (47.7)
Isthmus 5 (1.5)
Composition Spongiform 4 (1.2)
Cystic 0 (0)
Mixed 72 (21.9)
Solid 251 (76.3)
Undetermined because of calcification 2 (0.6)
Echogenicityc Anechoic 0 (0)
Hyperechoic 11 (3.4)
Isoechoic 260 (79.0)
Hypoechoic 58 (17.6)
Very hypoechoic 0 (0)
Margin Smooth 303 (92.1)
Ill-defined 25 (7.6)
Irregular 1 (0.3)
Calcificationsb Absent 282 (85.7)
Microcalcification 16 (4.9)
Macrocalcification 26 (7.9)
Rim calcification 7 (2.1)
Shape Round to oval 316 (96.0)
Irregular 13 (4.0)
Orientation Parallel 328 (99.7)
Nonparallel 1 (0.3)
Peripheral halo Present 194 (59.0)
Hyperechoic foci Comet-tail artifacts 4 (1.2)
Indeterminate 3 (0.9)
Extrathyroidal extension Present 1 (0.3)
Suspicious cervical lymph node Present 3 (0.9)
The location of the solid component for mixed-content nodules Eccentric 21 (29.2)
Non-eccentric 51 (70.8)
Vascularization Absent 11 (3.3)
Perinodular 6 (1.8)
Intranodular 6 (1.8)
Mixed 306 (93.1)
Ultrasound-based malignancy risk stratification systems
ATA Benign 0 (0)
Very low suspicion 53 (16.1)
Low suspicion 213 (64.7)
Intermediate suspicion 37 (11.3)
High suspicion 8 (2.4)
Nonclassifiable group 18 (5.5)
AACE/ACE/AME Low 11 (3.4)
Intermediate 293 (89.0)
High suspicion 18 (5.5)
Nonclassifiable group 7 (2.1)
K-TIRADS Benign (K-TR2) 8 (2.4)
Low suspicion (K-TR3) 258 (78.5)
Intermediate suspicion (K-TR4) 53 (16.1)
High suspicion (K-TR5) 8 (2.4)
Nonclassifiable group 12 (3.6)
EU-TIRADS Benign (EU-TR2) 4 (1.2)
Low risk (EU-TR3) 252 (76.5)
Intermediate risk (EU-TR4) 38 (11.6)
High risk (EU-TR5) 24 (7.3)
Nonclassifiable group 11 (3.4)
ACR-TIRADS Benign (ACR-TR1) 4 (1.2)
Not suspicious (ACR-TR2) 62 (18.8)
Mildly suspicious (ACR-TR3) 185 (56.3)
Moderately suspicious (ACR-TR4) 70 (21.3)
Highly Suspicious (ACR-TR5) 8 (2.4)
C-TIRADS C-TR2 8 (2.4)
C-TR3 67 (20.4)
C-TR4A 224 (68.1)
C-TR4B 19 (5.8)
C-TR4C 8 (2.4)
C-TR5 3 (0.9)

aThe maximum diameters could not be determined in a case due to macrocalcifications

bSome nodules presented multiple types of calcifications

cHyperechoic, isoechoic and hypoechoic: compared to adjacent parenchyma; very hypoechoic: more hypoechoic than strap muscles

Abbreviations: FTA follicular thyroid adenoma; FTC follicular thyroid carcinoma; ATA 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer; AACE/ACE/AME American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinology Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules (2016 Update); EU-TIRADS European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults; K-TIRADS Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations; ACR-TIRADS American College of Radiology Thyroid Imaging Reporting and Data System; C-TIRADS 2020 Chinese Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules